Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2019 3
2020 2
2021 3
2022 10
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance.
Visentin A, Pravato S, Castellani F, Campagnolo M, Angotzi F, Cavarretta CA, Cellini A, Ruocco V, Salvalaggio A, Tedeschi A, Trentin L, Briani C. Visentin A, et al. Among authors: pravato s. Cancers (Basel). 2022 Mar 18;14(6):1562. doi: 10.3390/cancers14061562. Cancers (Basel). 2022. PMID: 35326711 Free PMC article. Review.
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia.
Visentin A, Frezzato F, Severin F, Imbergamo S, Pravato S, Romano Gargarella L, Manni S, Pizzo S, Ruggieri E, Facco M, Brunati AM, Semenzato G, Piazza F, Trentin L. Visentin A, et al. Among authors: pravato s. Onco Targets Ther. 2020 Sep 29;13:9679-9688. doi: 10.2147/OTT.S268899. eCollection 2020. Onco Targets Ther. 2020. PMID: 33061448 Free PMC article. Review.
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Gotti M, Sciarra R, Pulsoni A, Merli F, Luminari S, Zerbi C, Trentin L, Re A, Rusconi C, Viviani S, Rossi A, Cocito F, Botto B, Meli E, Pinto A, Dogliotti I, Gini G, Puccini B, Ricci F, Nassi L, Fabbri A, Liberati AM, Merli M, Filippi AR, Bonfichi M, Zoboli V, Tartaglia G, Annechini G, D'Elia GM, Del Giudice I, Alvarez I, Visentin A, Pravato S, Dalceggio D, Pagani C, Ferrari S, Cristinelli C, Lazic T, Ferretti VV, Ricardi U, Arcaini L. Gotti M, et al. Among authors: pravato s. Hemasphere. 2023 Apr 4;7(4):e837. doi: 10.1097/HS9.0000000000000837. eCollection 2023 Apr. Hemasphere. 2023. PMID: 37034003 Free PMC article.
Multifocal recurrent neuralgic amyotrophy in an immunocompromised patient.
Briani C, Salvalaggio A, Anglani M, Imbergamo S, Pravato S, Marasca M, Cacciavillani M, Gasparotti R. Briani C, et al. Among authors: pravato s. J Neurol. 2024 Mar;271(3):1080-1083. doi: 10.1007/s00415-023-12157-4. Epub 2024 Jan 7. J Neurol. 2024. PMID: 38184820 No abstract available.
Anaemia during venetoclax ramp-up phase: Do not forget unusual causes.
Cavarretta CA, Visentin A, Pravato S, Piva E, Piazza F, Basso D, Trentin L. Cavarretta CA, et al. Among authors: pravato s. Int J Lab Hematol. 2022 Oct;44(5):e211-e214. doi: 10.1111/ijlh.13875. Epub 2022 May 11. Int J Lab Hematol. 2022. PMID: 35538897 No abstract available.
Relevance of bone marrow histology in challenging cases of Acute Myeloid Leukemia.
Pizzi M, Sbaraglia M, De Bartolo D, Dal Santo L, Binotto G, Tosato F, Pravato S, Scapinello G, Martines A, Bonaldi L, Dei Tos AP. Pizzi M, et al. Among authors: pravato s. Int J Lab Hematol. 2022 Jun;44(3):e107-e110. doi: 10.1111/ijlh.13750. Epub 2021 Nov 1. Int J Lab Hematol. 2022. PMID: 34725915 No abstract available.
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Angotzi F, Petrella M, Berno T, Binotto G, Bonetto G, Branca A, Carraro M, Cavaretta CA, Cellini A, D'Amore F, Forlani L, Gianesello I, Gurrieri C, Imbergamo S, Lessi F, Maroccia A, Mazzetto F, Pavan L, Pezone S, Piazza F, Pravato S, Ruocco V, Scapinello G, Vianello F, Zambello R, Zatta I, Zoletto S, Padoan A, Trentin L, Visentin A. Angotzi F, et al. Among authors: pravato s. Front Oncol. 2023 Jun 22;13:1212752. doi: 10.3389/fonc.2023.1212752. eCollection 2023. Front Oncol. 2023. PMID: 37427126 Free PMC article.
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study.
Visentin A, Mauro FR, Cibien F, Vitale C, Reda G, Fresa A, Ciolli S, Pietrasanta D, Marchetti M, Murru R, Gentile M, Rigolin GM, Quaglia FM, Scarfò L, Sportoletti P, Pravato S, Piazza F, Coscia M, Laurenti L, Molica S, Foà R, Cuneo A, Trentin L. Visentin A, et al. Among authors: pravato s. Am J Hematol. 2022 Mar 1;97(3):E95-E99. doi: 10.1002/ajh.26437. Epub 2021 Dec 21. Am J Hematol. 2022. PMID: 34904743 Free article. Clinical Trial. No abstract available.
23 results